Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

MD Medical Group Investments Plc, an investment holding company, operates a chain of clinics that provide healthcare services for women and children in Russia. It offers a range of services in the areas of obstetrics and gynecology, fertility and in-vitro fertilization treatment, and pediatrics, as well as diagnostics, urology, surgery, traumatology, rehabilitation, cardiology, oncology, dental care, stem cell storage, laboratory testing, phlebology, endocrinology, hematology, and others. The company also retails pharmaceutics; provides assistance and rental services; and operates as a management company, as well as holds land. As of September 18, 2018, it managed 39 healthcare facilities, including 5 hospitals and 34 outpatient clinics in Moscow and the Moscow Region, Tula, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, and Volgograd. The company was founded in 2006 and is headquartered in Nicosia, Cyprus. MD Medical Group Investments Plc is a subsidiary of MD Medical Holding Limited.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 3.63
3.40
2.21
1.77
2.53
3.03
2.71
growth rate -6.3% -35.0% -19.9% 42.9% 19.8% -10.6%
Earnings BIT 1,535.88
1,775.04
2,723.72
3,226.12
growth rate 15.6% 53.5% 18.5%
Avg.PE 4.48
4.48
growth rate 0.0%
ROA 31.11
38.06
18.03
15.83
4.79
8.05
9.64
11.50
12.14
11.28
growth rate 22.3% -52.6% -12.2% -69.7% 68.1% 19.8% 19.3% 5.6% -7.1%
ROE 65.43
70.35
33.33
25.77
7.44
12.88
15.39
17.63
18.79
17.91
growth rate 7.5% -52.6% -22.7% -71.1% 73.1% 19.5% 14.6% 6.6% -4.7%
ROIC 45.11
56.63
23.40
18.83
7.21
11.16
13.49
15.14
15.64
14.17
growth rate 25.5% -58.7% -19.5% -61.7% 54.8% 20.9% 12.2% 3.3% -9.4%
Cur. Ratio 0.40
0.46
0.28
3.62
1.79
0.56
0.82
0.77
1.01
1.05
growth rate 15.0% -39.1% 1,192.9% -50.6% -68.7% 46.4% -6.1% 31.2% 4.0%
Quick Ratio 0.35
0.41
0.21
3.57
1.70
0.41
0.66
0.61
0.82
0.84
growth rate 17.1% -48.8% 1,600.0% -52.4% -75.9% 61.0% -7.6% 34.4% 2.4%
Leverage 2.10
1.67
1.85
1.56
1.55
1.65
1.55
1.52
1.57
1.60
growth rate -20.5% 10.8% -15.7% -0.6% 6.5% -6.1% -1.9% 3.3% 1.9%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 169.77
80.88
160.31
178.58
359.86
325.83
growth rate -52.4% 98.2% 11.4% 101.5% -9.5%
Acct.Payable 605.40
86.49
194.74
214.83
323.37
318.73
growth rate -85.7% 125.2% 10.3% 50.5% -1.4%
Cur.Assets 4,251.45
2,839.64
1,441.30
2,412.51
2,503.00
3,479.73
growth rate -33.2% -49.2% 67.4% 3.8% 39.0%
Total Assets 10,341.53
10,930.12
16,074.24
17,207.81
18,715.77
22,271.95
growth rate 5.7% 47.1% 7.1% 8.8% 19.0%
Cash 2,068.47
2,621.02
890.55
1,774.31
1,642.94
2,504.60
growth rate 26.7% -66.0% 99.2% -7.4% 52.5%
Inventory 40.04
88.89
267.90
327.37
445.18
525.36
growth rate 122.0% 201.4% 22.2% 36.0% 18.0%
Cur.Liabilities 1,174.77
1,583.18
2,555.85
2,941.79
3,259.29
3,446.39
growth rate 34.8% 61.4% 15.1% 10.8% 5.7%
Liabilities 3,435.43
3,554.75
5,937.65
5,698.40
5,945.63
7,704.29
growth rate 3.5% 67.0% -4.0% 4.3% 29.6%
LT Debt 2,158.16
1,905.10
3,251.06
2,292.57
2,199.77
3,585.21
growth rate -11.7% 70.7% -29.5% -4.1% 63.0%
Equity 9,754.28
11,086.68
12,347.29
14,141.72
growth rate 13.7% 11.4% 14.5%
Common Shares 72,125.00
72,125.00
63.00
65.00
75.00
75.00
75.00
75.00
75.00
75.00
growth rate 0.0% -99.9% 3.2% 15.4% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 2,118.92
1,945.94
3,125.62
779.84
1,716.10
3,445.03
growth rate -8.2% 60.6% -75.1% 120.1% 100.8%
Cash Dividends 180.27
300.33
785.81
680.79
growth rate 66.6% 161.7% -13.4%
Cash From OA 1,455.05
1,330.93
2,106.52
2,818.22
3,860.83
4,185.87
growth rate -8.5% 58.3% 33.8% 37.0% 8.4%
FCF per Share -0.42
-0.22
-0.35
-0.19
0.52
0.46
0.14
growth rate 0.0% 0.0% 0.0% 100.0% -11.5% -69.6%
FCF 797.00
907.00
-737.00
-830.00
-823.00
-1,028.00
2,031.00
2,113.00
723.00
477.00
growth rate 13.8% -100.0% 0.0% 0.0% 0.0% 100.0% 4.0% -65.8% -34.0%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 3,252.05
4,542.94
7,200.93
9,506.80
12,179.08
13,755.17
growth rate 39.7% 58.5% 32.0% 28.1% 12.9%
Op.Income 1,231.63
611.81
1,535.88
1,775.04
2,723.72
3,226.12
growth rate -50.3% 151.0% 15.6% 53.5% 18.5%
IBT 1,394.80
1,804.94
2,239.11
2,781.16
growth rate 29.4% 24.1% 24.2%
Net Income 1,231.63
611.81
1,195.69
1,603.53
2,065.85
2,488.81
growth rate -50.3% 95.4% 34.1% 28.8% 20.5%
EPS 0.01
0.01
13.76
21.46
8.47
15.94
21.41
27.58
33.23
35.61
growth rate 0.0% 137,500.0% 56.0% -60.5% 88.2% 34.3% 28.8% 20.5% 7.2%
Gross Profit 1,683.28
1,949.15
3,045.65
3,687.08
4,875.80
5,526.67
growth rate 15.8% 56.3% 21.1% 32.2% 13.4%

Quarterly Statements

Item Name Jun '16 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 892.31
892.31
678.66
678.66
growth rate 0.0% -23.9% 0.0%
Balance Sheet Jun '16 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 189.79
325.83
325.83
310.19
310.19
growth rate 71.7% 0.0% -4.8% 0.0%
Acct.Payable 869.67
318.73
318.73
1,386.74
1,386.74
growth rate -63.4% 0.0% 335.1% 0.0%
Cur.Assets 1,636.03
3,479.73
3,479.73
2,933.26
2,933.26
growth rate 112.7% 0.0% -15.7% 0.0%
Total Assets 14,030.82
22,271.95
22,271.95
22,805.87
22,805.87
growth rate 58.7% 0.0% 2.4% 0.0%
Cash 1,021.02
2,504.60
2,504.60
1,966.04
1,966.04
growth rate 145.3% 0.0% -21.5% 0.0%
Inventory 293.09
525.36
525.36
534.11
534.11
growth rate 79.3% 0.0% 1.7% 0.0%
Cur.Liabilities 2,547.34
3,446.39
3,446.39
3,374.13
3,374.13
growth rate 35.3% 0.0% -2.1% 0.0%
Liabilities 4,504.50
7,704.29
7,704.29
8,356.30
8,356.30
growth rate 71.0% 0.0% 8.5% 0.0%
LT Debt 1,587.99
3,585.21
3,585.21
4,134.92
4,134.92
growth rate 125.8% 0.0% 15.3% 0.0%
Equity 14,141.72
14,141.72
14,165.42
14,165.42
growth rate 0.0% 0.2% 0.0%
Common Shares 180.59
180.59
180.59
180.59
growth rate 0.0% 0.0% 0.0%
Cash Flow Statement Jun '16 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures 210.61
1,297.22
1,297.22
830.08
830.08
growth rate 515.9% 0.0% -36.0% 0.0%
Cash Dividends 176.43
176.43
247.17
247.17
growth rate 0.0% 40.1% 0.0%
Cash From OA 715.92
1,095.79
1,095.79
960.63
960.63
growth rate 53.1% 0.0% -12.3% 0.0%
FCF 505.30
-201.43
-201.43
130.54
130.54
growth rate -100.0% 0.0% 100.0% 0.0%
Income Statement Jun '16 Sep '17 Dec '17 Mar '18 Jun '18
Sales 2,327.93
3,568.82
3,568.82
3,565.22
3,565.22
growth rate 53.3% 0.0% -0.1% 0.0%
Op.Income 394.79
892.31
892.31
678.66
678.66
growth rate 126.0% 0.0% -23.9% 0.0%
IBT 783.64
783.64
642.21
642.21
growth rate 0.0% -18.1% 0.0%
Net Income 394.79
680.94
680.94
570.24
570.24
growth rate 72.5% 0.0% -16.3% 0.0%
Gross Profit 908.91
1,491.62
1,491.62
1,294.05
1,294.05
growth rate 64.1% 0.0% -13.3% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (61.77)

YOY Growth Grade:

D (49.80)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 4.48 464.68
EPS / Growth 0.01

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 13.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 13.6% 13.6% 13.6%
Future PE 0.01 2.99 10.53
Future EPS 0.04 0.04 0.04
Value Price
MOS %
0.00
0.03
0.10
MOS Price 0.00 0.01 0.05
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.